Scope
NICE guideline NG152 covers antimicrobial prescribing for leg ulcer infection in adults. It defines a leg ulcer as a chronic open wound that is slow to heal, usually on the lower leg. The guideline stresses that most leg ulcers are colonised rather than clinically infected, and that underlying causes need managing. It reserves antibiotics for clinical signs of infection. It also covers microbiological sampling, patient advice, reassessment, hospital referral and specialist advice. Table 1 sets out oral and intravenous antibiotic choices for adults aged 18 and over. These include regimens for people who are severely unwell and add-on agents for suspected or confirmed meticillin-resistant Staphylococcus aureus (MRSA).
Written by House with AI assistance · AI-assisted source check 29 October 2026.
This is House’s summary of the cited guidance. The source check is not an independent clinician review. Open the publication for complete recommendations, exceptions, evidence grades and later amendments.
Principles and when to treat
- Leg ulcers have many causes. Underlying conditions such as venous insufficiency and oedema should be managed to help the ulcer heal. [1]
- Most leg ulcers are likely to be colonised by bacteria but are not clinically infected. Antibiotics do not promote healing of an ulcer that is not infected. [1]
- Do not take a microbiological sample from a leg ulcer at first presentation, even if infection is possible. [1]
- Offer adults an antibiotic only when there are symptoms or signs of infection. Examples are spreading redness or swelling beyond the ulcer, local warmth, increased pain or fever. Base the choice of antibiotic on severity, risk of complications and previous antibiotic use. [1]
- Use oral antibiotics if the person can take oral medicines and their condition is not severe enough to need intravenous treatment. If intravenous antibiotics are given, review them by 48 hours and consider switching to oral where possible. [1]
Advice and reassessment
- When prescribing for an infected leg ulcer in adults, advise the person to seek help if the infection worsens rapidly or significantly at any time, or has not started improving within 2 to 3 days of starting treatment. [1]
- Reassess an infected leg ulcer in adults in any of these situations: rapid or significant worsening, no improvement within 2 to 3 days, the person becomes systemically unwell, or pain is severe and out of proportion to the infection. [1]
- At reassessment, take account of previous antibiotic use, which may have led to resistant bacteria. Infection takes time to resolve, and full resolution is not expected until after the course is finished. [1]
- If the infection is worsening or not improving as expected, consider sending a sample for microbiological testing, taken after cleaning the ulcer. When results are available, review the antibiotic choice. If the person is not improving, change treatment according to the results, using a narrow-spectrum agent where possible. [1]
Referral and specialist advice
- Refer adults with an infected leg ulcer to hospital if any features suggest a more serious illness, such as sepsis, necrotising fasciitis or osteomyelitis. [1]
- For adults with an infected leg ulcer, consider referral or specialist advice in four situations: - higher risk of complications from comorbidities such as diabetes or immunosuppression - lymphangitis - spreading infection not responding to oral antibiotics - inability to take oral antibiotics. In this case, explore local options for intravenous or intramuscular treatment at home or in the community where appropriate. [1]
Oral antibiotic choice (adults 18 and over)
- The first-choice oral antibiotic is flucloxacillin 500 mg to 1 g four times daily for 7 days. The 1 g dose was off label in February 2020. [1]
- Alternative first-choice oral antibiotics for penicillin allergy, or if flucloxacillin is unsuitable, are: - doxycycline 200 mg on day one, then 100 mg once daily (can be increased to 200 mg daily), for 7 days in total - clarithromycin 500 mg twice daily for 7 days - erythromycin 500 mg four times daily for 7 days in pregnancy. [1]
- Erythromycin is the preferred macrolide in pregnancy, for example with true penicillin allergy where the benefits of treatment outweigh the harms. [1]
- Second-choice oral options, guided by microbiological results when available, are co-amoxiclav 500/125 mg three times daily for 7 days, or co-trimoxazole 960 mg twice daily for 7 days in penicillin allergy. Co-trimoxazole was off label for leg ulcer infection in February 2020; see the BNF for monitoring. [1]
Antibiotics if severely unwell
- First-choice options when severely unwell, guided by microbiological results if available, are: - intravenous flucloxacillin 1 g to 2 g four times daily, with or without gentamicin and/or metronidazole - intravenous co-amoxiclav 1.2 g three times daily, with or without gentamicin. [1]
- As a first-choice option for severely unwell adults with penicillin allergy, guided by microbiological results if available, intravenous co-trimoxazole 960 mg twice daily can be used. The dose is increased to 1.44 g twice daily for severe infection. It can be given with or without gentamicin and/or metronidazole. Co-trimoxazole was off label for leg ulcer infection in February 2020; see the BNF for monitoring. [1]
- Gentamicin starts at 5 mg/kg to 7 mg/kg intravenously once daily. Any further doses are based on serum gentamicin levels; see the BNF for monitoring. Metronidazole, where used as an add-on, is given as 400 mg three times daily orally or 500 mg three times daily intravenously. [1]
- Second-choice options when severely unwell are guided by microbiological results when available or by specialist advice. They are: - piperacillin with tazobactam 4.5 g three times daily intravenously (four times daily if severe infection) - ceftriaxone 2 g once daily intravenously, with or without metronidazole. [1]
Add-on antibiotics for suspected or confirmed MRSA
- If MRSA infection is suspected or confirmed, add an agent as combination therapy with the antibiotics listed above in the table. Options include: - intravenous vancomycin 15 mg/kg to 20 mg/kg two or three times daily (maximum 2 g per dose), adjusted to serum vancomycin levels - teicoplanin 6 mg/kg every 12 hours for three doses, then 6 mg/kg once daily intravenously. See the BNF for monitoring. [1]
- Linezolid 600 mg twice daily, orally or intravenously, is a further add-on option for suspected or confirmed MRSA, given in combination with the antibiotics listed above in the table. It is for use only if vancomycin or teicoplanin cannot be used, and on specialist advice only. See the BNF for monitoring. [1]
General dosing notes
- Check the BNF for use and dosing in specific groups, including hepatic or renal impairment, pregnancy and breastfeeding, and for parenteral administration. [1]
Limitations and use
- Applies only to adults; the antibiotic choices in Table 1 are for those aged 18 years and over.
- Research recommendations, committee rationale and evidence summaries were not included in the reviewed extract.
- Off-label status statements reflect February 2020. Dosing in renal or hepatic impairment, pregnancy and breastfeeding is deferred to the BNF.
- Table 1 combination options are complex; consult the original table layout for exact pairings.
This summary is selective and does not reproduce every recommendation. Apply the source’s population, setting and eligibility criteria, together with clinical judgement and local policy.
Summary sources
- Leg ulcer infection: antimicrobial prescribing
Guideline recommendation text consulted
Publication details
- Issuing organisation
- NICE
- First published
- 11 February 2020
- Resource type
- Clinical guideline · House clinical summary
The source check confirms publication details and the linked edition. It does not certify every recommendation or its suitability for an individual patient. Publisher access conditions may apply.